Accueil/Actions/NKTX

NKTX

USD

Nkarta Inc. Common Stock

$1.970-0.040 (-1.990%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.010

Haut

$2.055

Bas

$1.960

Volume

0.61M

Fondamentaux de l'Entreprise

Capitalisation Boursière

139.9M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.86M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $1.31Actuel $1.970Haut $3.81

Actualités Connexes

30 oct. 2025 · 17:14

GlobeNewswire

Nkarta to Participate in November Investor Conferences

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its

Nkarta to Participate in November Investor Conferences

22 oct. 2025 · 14:07

GlobeNewswire

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune